Your Unread Messages in Gastroenterology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
No association exists between PPIs and H2 blockers and Clostridium difficile
Smartest Doc Challenge
MDLinx
How common is Lynch Syndrome and are patients at an increased risk for other cancers because of it?
Steve Smith
Executive Editor, MDLinx
3,000+ new jobs posted this week
1 Vitamin D Status and Per-oral Vitamin D Supplementation in Patients Suffering from Chronic Pancreatitis and Pancreatic Cancer Disease Anticancer Research, May 17, 2012 Clinical Article
2 Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level Journal of Gastroenterology, May 17, 2012 Clinical Article
3 Combination Therapy with Gemcitabine (GEM) and Erlotinib (E) in Exocrine Pancreatic Cancer under Special Reference to RASH and the Tumour Marker CA19-9 Anticancer Research, May 17, 2012 Clinical Article
4 The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea Alimentary Pharmacology and Therapeutics, May 17, 2012 Clinical Article
5 LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients Hepatology, May 17, 2012 Clinical Article
6 Cytokeratin Serum Biomarkers in Patients with Colorectal Cancer Anticancer Research, May 17, 2012 Clinical Article
7 Helicobacter pylori infection: what's new Current Opinion in Infectious Diseases, May 17, 2012
8 The Survivin Suppressant YM155 Potentiates Chemosensitivity to Gemcitabine in the Human Pancreatic Cancer Cell Line MiaPaCa-2 Anticancer Research, May 17, 2012 Clinical Article
9 Expression Levels of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Thymidine Phosphorylase in Patients with Colorectal Cancer Anticancer Research, May 17, 2012 Clinical Article
10 Mucosal healing in Crohns disease: A systematic review Inflammatory Bowel Disease, May 17, 2012 Evidence Based Medicine
11 Incidence of Peptic Ulcer Bleeding in the US Pediatric Population Journal of Pediatric Gastroenterology and Nutrition, May 17, 2012
12 Healthcare Utilization and Comorbidity Burden among Children and Young Adults in the United States with Systemic Lupus Erythematosus or Inflammatory Bowel Disease The Journal of Pediatrics, May 17, 2012
13 Antibiotics as First-line Therapy for Acute Appendicitis: Evidence for a Change in Clinical Practice World Journal of Surgery, May 17, 2012 Clinical Article
14 Which is the best MRI marker of malignancy for atypical cirrhotic nodules: Hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration Journal of Magnetic Resonance Imaging, May 17, 2012
15 Classification of Gastritis in First-degree Relatives of Patients with Gastric Cancer in a High Cancer-risk Area in Italy Anticancer Research, May 17, 2012
16 Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study Journal of Viral Hepatitis, May 17, 2012
17 Growth and metabolic control in patients with type 1 diabetes and celiac disease: a longitudinal observational case-control study Pediatric Diabetes, May 17, 2012
18 Decrease of CD44-positive Cells Correlates with Tumor Response to Chemotherapy in Patients with Gastrointestinal Cancer Anticancer Research, May 17, 2012
19 Molecular Testing in Colorectal Cancer: Diagnosis of Lynch Syndrome and Personalized Cancer Medicine American Journal of Clinical Pathology, May 17, 2012
20 Esophageal Endoscopic Dilations Journal of Pediatric Gastroenterology and Nutrition, May 17, 2012
New Topics in Gastroenterology
See All >>1 Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate Helicobacter, April 6, 2012
2 Adalimumab in steroid-dependent Crohns disease patients: Prognostic factors for clinical benefit Inflammatory Bowel Disease, April 17, 2012
3 Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohns Disease Gastroenterology, February 29, 2012
4 Serrated Polyp Detection Rate During Screening Colonoscopy Colorectal Disease, March 14, 2012
5 High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures Alimentary Pharmacology and Therapeutics, March 12, 2012
6 Natalizumab for moderate to severe Crohns disease in clinical practice Inflammatory Bowel Disease, April 3, 2012
7 Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease Inflammatory Bowel Disease, April 23, 2012
8 Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals Gastroenterology, April 6, 2012
9 Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori Helicobacter, April 11, 2012
10 Natalizumab for moderate to severe Crohns disease in clinical practice Inflammatory Bowel Disease, April 18, 2012
11 Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains Helicobacter, April 13, 2012
12 Scheduled infliximab monotherapy to prevent recurrence of Crohns disease following ileocolic or ileal resection: A 3-year prospective randomized open trial Inflammatory Bowel Disease, April 20, 2012
13 Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease Inflammatory Bowel Disease, April 16, 2012
14 Assessment of Helicobacter pylori Eradication by Virgin Olive Oil Helicobacter, April 24, 2012
15 Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing Diseases of the Esophagus, April 27, 2012
16 Vaniprevir with peginterferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C - a randomized phase 2 study Hepatology, April 19, 2012
17 Systematic review: antibodies and anti-TNF- levels in inflammatory bowel disease Alimentary Pharmacology and Therapeutics, April 12, 2012
18 Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis Journal of Digestive Diseases, March 27, 2012 Evidence Based Medicine
19 Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial The Lancet Infectious Diseases, March 27, 2012
20 The Association Between Barretts Esophagus and Helicobacter pylori Infection: A Meta-Analysis Helicobacter, April 3, 2012
Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gut more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close